DOCSLIB.ORG

Leveraging Large-Scale Datasets to Understand

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

LEVERAGING LARGE-SCALE DATASETS TO UNDERSTAND THE INTERACTION BETWEEN THE GENOME AND THE EPIGENOME by Leandros Boukas A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy. Baltimore, Maryland June, 2020 c 2020 Leandros Boukas All rights reserved Abstract Epigenetics is typically described as a layer of molecular information above and beyond the DNA sequence. While this conceptualization is certainly ac- curate to some extent, there is also a tight connection between the genome and the epigenome, as the basic components of the epigenetic machinery (EM) are DNA-encoded. This thesis focuses on four such genetic components: genes encoding for the proteins of the histone machinery, genes encoding for the pro- teins of the DNA methylation machinery, genes encoding for chromatin remod- elers, and CpG dinucleotides. We first perform a systematic analysis of all human EM genes, and characterize them with respect to their tolerance to variation, both at the whole-gene level, and the local, protein domain level. We then discover a systems-level property (co-expression), that is specifically exhibited by a large subset of variation-intolerant EM genes, and may be par- ticularly relevant to their involvement in neurodevelopment. Finally, we shift our focus on the CpG dinucleotides. We show that a high promoter CpG density is not merely a generic feature of human promoters, but is preferentially en- ii ABSTRACT countered at the promoters of the most loss-of-function intolerant genes. This coupling calls into question the prevailing view that CpG islands are not sub- ject to selection. It also has practical utility, as it allows us to train a simple and easily interpretable predictive model of loss-of-function intolerance that outperforms existing predictors and classifies 1,760 genes - which are currently unascertained - as highly loss-of-function-intolerant or not. Together, the re- sults presented in this thesis provide new insights into the interaction between the genome and the epigenome. Advisors and Readers: Kasper Daniel Hansen, PhD, and Hans Tomas Bjornsson, MD, PhD iii Acknowledgments I am indebted to many individuals for their contribution to my work during the past 5 years. First and foremost, I am deeply grateful to my advisors, Kasper and Hans. While having two advisors is not always guaranteed to succeed, in my case it was a true blessing and privilege. In particular, I would have never gotten accepted into the Human Genetics PhD program at Johns Hopkins, if Hans hadn’t generously offered me the op- portunity to work in his lab as a visiting student in the summer of 2014. Since then, I have watched from the front seat how he asks bold and important sci- entific questions, how he attacks them from many possible angles, and how he has developed a groundbreaking research program aimed at finding cures for his patients, while always keeping an eye on the basic science. For a budding physician-scientist like me, Hans is an ideal role model. Aside from allowing me to get into this PhD program, Hans did another cru- cial thing for my training: he suggested that I work with Kasper. Following this suggestion turned out to be one of the best decisions I have ever made. Data iv ACKNOWLEDGMENTS analysis is both a science and an art, that I believe is impossible to truly learn unless one works closely, and for an extended period of time, with a true expert. I have seen how Kasper uses his solid foundation in theoretical statistics, and an understanding of biology that, over the years, has become as deep as that of biologists, to approach meaningful problems in a manner that is both rigorous and intuitive. Whenever I walked into his office confused about some analysis, I always, without exception, walked out with things being much clearer in my head. I have also learned quite a lot from our many discussions over lunch, which I have very much enjoyed. Finally, I greatly appreciate the total freedom Kasper and Hans have given me to explore my own ideas, even when they are not directly related to their other research projects. If I manage to be half as good of an advisor as they have been to me, my future students will be extremely lucky. I also have to give special thanks to Dr. Valle and Sandy. I am very proud to call myself a product of the Human Genetics program, and it’s clear that their deep commitment is one of the driving forces behind it. They have created an environment where it is possible for us students to live and breathe genetics. The many departmental activities and courses have certainly helped me ac- quire breadth that I would not have acquired had I only been focused on my own research. Thanks to my thesis committee members, Dr. Valle, Dani Fallin, and Alexis v ACKNOWLEDGMENTS Battle. I especially want to thank Alexis who provided us with constructive feedback for the co-expression analysis. I also thank Jill Fahrner, with whom we have joint lab meetings, and who has often provided me with very useful feedback. Thanks also to Loyal Goff and Dimitrios Avramopoulos, with whom I spent two very pleasant rotations in my first year. In addition, I have had some very stimulating interactions and discussions with Kirby Smith, Barbara Migeon, Haig Kazazian, and Stephanie Hicks. Sincere thanks to Priya Duggal and Jennifer Deal, who accepted me into the MD-GEM program. The courses I took as part of it definitely helped me understand how to think about population-scale genetics. Of course, I want to also thank my classmates. It has been great to have their friendship and support, and to be able to share this journey with them. I have also been very fortunate to have friends outside Hopkins, with whom we made some great memories. Thanks to Thanos, Kleio, Chris, Maria, Greta, and Antonis. Very special thanks have to go to Ilias and Mike (who is my best friend from med school and now also my roommate) - I hope the three of us will continue to share this journey through residency training. I am grateful to the Jenkins family - Stella, Larry, Christian, and Daniel. Ever since I came to Baltimore they adopted me as their third child (which, of course, they didn’t have to do), and it has been great to know that I have a vi ACKNOWLEDGMENTS family here, even though my real parents are far away. I don’t need to say much about my best friends from Greece - Thomas, Ja- nis, Kostas, Dimitris, and Iordanis. Ever since we graduated from college we disseminated around the globe, but our friendship (brotherhood, indeed) has no borders. The final year of my PhD was by far the happiest for me. There is only one reason for this, which has nothing to do with the science. It is that I have been able to share my life with Giota, and I look forward to many more years with her. Last, but not least, I wouldn’t be standing here without the endless and unconditional love and support from my parents, Effie and Andreas, who is also responsible for inspiring my love for science. I wholeheartedly dedicate this thesis to them. vii To my mom and dad viii Contents Abstract ii Acknowledgments iv List of Tables xv List of Figures xvi 1 Introduction 1 2 Co-expression patterns define epigenetic regulators associated with neurological dysfunction 5 2.1 Preface . 5 2.2 Introduction . 5 2.3 Results . 7 2.3.1 The modular composition of the epigenetic machinery . 7 2.3.2 The human epigenetic machinery is highly intolerant to variation and contains many additional disease candidates 10 ix CONTENTS 2.3.3 Dual function epigenetic regulators and remodelers are the most variation-intolerant categories . 14 2.3.4 The intolerance to variation is primarily driven by the do- mains mediating the epigenetic function . 16 2.3.5 A large subset of the epigenetic machinery is co-expressed 19 2.3.6 Dual function epigenetic regulators are enriched in the highly co-expressed group and are co-expressed with mul- tiple other categories . 23 2.3.7 The highly co-expressed epigenetic regulators are extremely intolerant to variation and enriched for genes causing neu- rological dysfunction . 25 2.3.8 Brain-specific regulatory elements of highly co-expressed epigenetic regulators are enriched for SNPs that explain the heritability of common neurological traits. 28 2.3.9 The promoters of highly co-expressed genes of the epige- netic machinery are bound by common trans-acting factors 30 2.4 Discussion . 31 2.5 Methods . 35 2.5.1 The creation of an epigenetic regulator list . 35 2.5.2 Epigenetic regulators with disease associations . 37 2.5.3 Variation tolerance analysis . 40 x CONTENTS 2.5.4 CCR local constraint score . 40 2.5.5 GTEx data . 41 2.5.6 Tissue specificity and expression level analysis . 42 2.5.7 Co-expression analysis . 43 2.5.8 Trans-acting factor binding at EM gene promoters . 47 2.5.9 Enrichment of disease genes in the highly co-expressed group . 49 2.5.10 Stratified LD score regression . 50 2.5.11 Genome assembly version . 51 2.5.12 Code availability . 52 2.5.13 Acknowledgments . 52 2.6 Supplemental Materials . 53 2.6.1 Supplemental Results . 53 2.6.1.1 Variation intolerance of EM genes encoded on the sex chromosomes . 53 2.6.1.2 Tissue specificity and expression levels of EM genes 53 2.6.1.3 The highly co-expressed genes are not enriched for protein-protein interactions .
Recommended publications
  • Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis

    Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis

    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis.
  • Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice

    Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice

    Loyola University Chicago Loyola eCommons Biology: Faculty Publications and Other Works Faculty Publications 2013 Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice Mihaela Palicev Gunter P. Wagner James P. Noonan Benedikt Hallgrimsson James M. Cheverud Loyola University Chicago, [email protected] Follow this and additional works at: https://ecommons.luc.edu/biology_facpubs Part of the Biology Commons Recommended Citation Palicev, M, GP Wagner, JP Noonan, B Hallgrimsson, and JM Cheverud. "Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice." Genome Biology and Evolution 5(10), 2013. This Article is brought to you for free and open access by the Faculty Publications at Loyola eCommons. It has been accepted for inclusion in Biology: Faculty Publications and Other Works by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. © Palicev et al., 2013. GBE Genomic Correlates of Relationship QTL Involved in Fore- versus Hind Limb Divergence in Mice Mihaela Pavlicev1,2,*, Gu¨ nter P. Wagner3, James P. Noonan4, Benedikt Hallgrı´msson5,and James M. Cheverud6 1Konrad Lorenz Institute for Evolution and Cognition Research, Altenberg, Austria 2Department of Pediatrics, Cincinnati Children‘s Hospital Medical Center, Cincinnati, Ohio 3Yale Systems Biology Institute and Department of Ecology and Evolutionary Biology, Yale University 4Department of Genetics, Yale University School of Medicine 5Department of Cell Biology and Anatomy, The McCaig Institute for Bone and Joint Health and the Alberta Children’s Hospital Research Institute for Child and Maternal Health, University of Calgary, Calgary, Canada 6Department of Anatomy and Neurobiology, Washington University *Corresponding author: E-mail: [email protected].
  • Epigenome-Wide Association of Father's Smoking

    Epigenome-Wide Association of Father's Smoking

    Environmental Epigenetics, 2019, 1–10 doi: 10.1093/eep/dvz023 Research article RESEARCH ARTICLE Epigenome-wide association of father’s smoking with offspring DNA methylation: a hypothesis-generating study G.T. Mørkve Knudsen1,2,*,†, F.I. Rezwan3,†, A. Johannessen2,4, S.M. Skulstad2, R.J. Bertelsen1, F.G. Real1, S. Krauss-Etschmann5,6, V. Patil7, D. Jarvis8, S.H. Arshad9,10, J.W. Holloway3,‡ and C. Svanes2,4,‡ 1Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway; 2Department of Occupational Medicine, Haukeland University Hospital, N-5021 Bergen, Norway; 3Human Genetics and Genomic Medicine, Human Development and Health, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK; 4Department of Global Public Health and Primary Care, Centre for International Health, University of Bergen, N-5018 Bergen, Norway; 5Division of Experimental Asthma Research, Research Center Borstel, 23845 Borstel, Germany; 6German Center for Lung Research (DZL) and Institute of Experimental Medicine, Christian- Albrechts University of Kiel, 24118 Kiel, Germany; 7David Hide Asthma and Allergy Research Centre, St. Mary’s Hospital, Isle of Wight PO30 5TG, UK; 8Faculty of Medicine, National Heart & Lung Institute, Imperial College, London SW3 6LY, UK; 9Clinical and Experimental Sciences, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK; 10NIHR Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton SO16 6YD, UK *Correspondence address. Haukanesvegen 260, N-5650 Tysse, Norway; Tel: þ47 977 98 147; E-mail: [email protected] and [email protected] †Equal first authors. ‡Equal last authors. Managing Editor: Moshe Szyf Abstract Epidemiological studies suggest that father’s smoking might influence their future children’s health, but few studies have addressed whether paternal line effects might be related to altered DNA methylation patterns in the offspring.
  • DNA Methylation Regulates Discrimination of Enhancers From

    DNA Methylation Regulates Discrimination of Enhancers From

    Sharifi-Zarchi et al. BMC Genomics (2017) 18:964 DOI 10.1186/s12864-017-4353-7 RESEARCHARTICLE Open Access DNA methylation regulates discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw mechanism Ali Sharifi-Zarchi1,2,3,4†, Daniela Gerovska5†, Kenjiro Adachi6, Mehdi Totonchi3, Hamid Pezeshk7,8, Ryan J. Taft9, Hans R. Schöler6,10, Hamidreza Chitsaz2, Mehdi Sadeghi8,11, Hossein Baharvand3,12* and Marcos J. Araúzo-Bravo5,13,14* Abstract Background: DNA methylation at promoters is largely correlated with inhibition of gene expression. However, the role of DNA methylation at enhancers is not fully understood, although a crosstalk with chromatin marks is expected. Actually, there exist contradictory reports about positive and negative correlations between DNA methylation and H3K4me1, a chromatin hallmark of enhancers. Results: We investigated the relationship between DNA methylation and active chromatin marks through genome- wide correlations, and found anti-correlation between H3K4me1 and H3K4me3 enrichment at low and intermediate DNA methylation loci. We hypothesized “seesaw” dynamics between H3K4me1 and H3K4me3 in the low and intermediate DNA methylation range, in which DNA methylation discriminates between enhancers and promoters, marked by H3K4me1 and H3K4me3, respectively. Low methylated regions are H3K4me3 enriched, while those with intermediate DNA methylation levels are progressively H3K4me1 enriched. Additionally, the enrichment of H3K27ac, distinguishing active from primed enhancers, follows a plateau in the lower range of the intermediate DNA methylation level, corresponding to active enhancers, and decreases linearly in the higher range of the intermediate DNA methylation. Thus, the decrease of the DNA methylation switches smoothly the state of the enhancers from a primed to an active state.
  • 4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation

    4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation

    Methods Mice: 4-6 weeks old female C57BL/6 mice obtained from Jackson labs were used for cell isolation. Female Foxp3-IRES-GFP reporter mice (1), backcrossed to B6/C57 background for 10 generations, were used for the isolation of naïve CD4 and naïve CD8 cells for the RNAseq experiments. The mice were housed in pathogen-free animal facility in the La Jolla Institute for Allergy and Immunology and were used according to protocols approved by the Institutional Animal Care and use Committee. Preparation of cells: Subsets of thymocytes were isolated by cell sorting as previously described (2), after cell surface staining using CD4 (GK1.5), CD8 (53-6.7), CD3ε (145- 2C11), CD24 (M1/69) (all from Biolegend). DP cells: CD4+CD8 int/hi; CD4 SP cells: CD4CD3 hi, CD24 int/lo; CD8 SP cells: CD8 int/hi CD4 CD3 hi, CD24 int/lo (Fig S2). Peripheral subsets were isolated after pooling spleen and lymph nodes. T cells were enriched by negative isolation using Dynabeads (Dynabeads untouched mouse T cells, 11413D, Invitrogen). After surface staining for CD4 (GK1.5), CD8 (53-6.7), CD62L (MEL-14), CD25 (PC61) and CD44 (IM7), naïve CD4+CD62L hiCD25-CD44lo and naïve CD8+CD62L hiCD25-CD44lo were obtained by sorting (BD FACS Aria). Additionally, for the RNAseq experiments, CD4 and CD8 naïve cells were isolated by sorting T cells from the Foxp3- IRES-GFP mice: CD4+CD62LhiCD25–CD44lo GFP(FOXP3)– and CD8+CD62LhiCD25– CD44lo GFP(FOXP3)– (antibodies were from Biolegend). In some cases, naïve CD4 cells were cultured in vitro under Th1 or Th2 polarizing conditions (3, 4).
  • Family-Based Exome Sequencing Identifies Rare Coding Variants in Age-Related Macular Degeneration Rinki Ratnapriya1,2,†,‡,, Ilhan˙ E

    Family-Based Exome Sequencing Identifies Rare Coding Variants in Age-Related Macular Degeneration Rinki Ratnapriya1,2,†,‡,, Ilhan˙ E

    Human Molecular Genetics, 2020, Vol. 29, No. 12 2022–2034 doi: 10.1093/hmg/ddaa057 Advance Access Publication Date: 3 April 2020 General Article GENERAL ARTICLE Family-based exome sequencing identifies rare coding variants in age-related macular degeneration Rinki Ratnapriya1,2,†,‡,, Ilhan˙ E. Acar3,†, Maartje J. Geerlings3, Kari Branham4, Alan Kwong5, Nicole T.M. Saksens3, Marc Pauper3, Jordi Corominas3, Madeline Kwicklis1, David Zipprer1, Margaret R. Starostik1, Mohammad Othman4,BeverlyYashar4, Goncalo R. Abecasis5, Emily Y. Chew1, Deborah A. Ferrington6, Carel B. Hoyng3, Anand Swaroop1,‡ and Anneke I. den Hollander3,‡,* 1Neurobiology, Neurodegeneration and Repair Laboratory (NNRL), National Eye Institute, Bethesda, MD 20892, USA, 2Department of Ophthalmology, Baylor College of Medicine, Houston, TX 77030, USA, 3Department of Ophthalmology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen 6500, The Netherlands, 4Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI 48105, USA, 5Center for Statistical Genetics, Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA and 6Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN 55455, USA *To whom correspondence should be addressed at: Department of Ophthalmology, Radboud University Medical Center, Philips van Leydenlaan 15, Route 409, Nijmegen 6525 EX, The Netherlands; Email: [email protected] Abstract Genome-wide association studies (GWAS) have identified 52 independent variants at 34 genetic loci that are associated with age-related macular degeneration (AMD), the most common cause of incurable vision loss in the elderly worldwide. However, causal genes at the majority of these loci remain unknown. In this study, we performed whole exome sequencing of 264 individuals from 63 multiplex families with AMD and analyzed the data for rare protein-altering variants in candidate target genes at AMD-associated loci.
  • Understanding Chronic Kidney Disease: Genetic and Epigenetic Approaches

    Understanding Chronic Kidney Disease: Genetic and Epigenetic Approaches

    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2017 Understanding Chronic Kidney Disease: Genetic And Epigenetic Approaches Yi-An Ko Ko University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Bioinformatics Commons, Genetics Commons, and the Systems Biology Commons Recommended Citation Ko, Yi-An Ko, "Understanding Chronic Kidney Disease: Genetic And Epigenetic Approaches" (2017). Publicly Accessible Penn Dissertations. 2404. https://repository.upenn.edu/edissertations/2404 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2404 For more information, please contact [email protected]. Understanding Chronic Kidney Disease: Genetic And Epigenetic Approaches Abstract The work described in this dissertation aimed to better understand the genetic and epigenetic factors influencing chronic kidney disease (CKD) development. Genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) significantly associated with chronic kidney disease. However, these studies have not effectively identified target genes for the CKD variants. Most of the identified variants are localized to non-coding genomic regions, and how they associate with CKD development is not well-understood. As GWAS studies only explain a small fraction of heritability, we hypothesized that epigenetic changes could explain part of this missing heritability. To identify potential gene targets of the genetic variants, we performed expression quantitative loci (eQTL) analysis, using genotyping arrays and RNA sequencing from human kidney samples. To identify the target genes of CKD-associated SNPs, we integrated the GWAS-identified SNPs with the eQTL results using a Bayesian colocalization method, coloc. This resulted in a short list of target genes, including PGAP3 and CASP9, two genes that have been shown to present with kidney phenotypes in knockout mice.
  • Associated with Tumorigenesis of Human Astrocytomas (Tumor Suppressor Genes/Antioncogenes/Brain Tumors/Neurofibromatosis/Colon Cancer) M

    Associated with Tumorigenesis of Human Astrocytomas (Tumor Suppressor Genes/Antioncogenes/Brain Tumors/Neurofibromatosis/Colon Cancer) M

    Proc. Nati. Acad. Sci. USA Vol. 86, pp. 7186-7190, September 1989 Medical Sciences Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas (tumor suppressor genes/antioncogenes/brain tumors/neurofibromatosis/colon cancer) M. EL-AzOUZI*, R. Y. CHUNG*, G. E. FARMER*, R. L. MARTUZA*, P. McL. BLACKt, G. A. ROULEAUt, C. HETTLICH*, E. T. HEDLEY-WHYTE§, N. T. ZERVAS*, K. PANAGOPOULOS*, Y. NAKAMURA¶, J. F. GUSELLAt, AND B. R. SEIZINGER*tII *Molecular Neurooncology Laboratory, Neurosurgery Service, tMolecular Neurogenetics Laboratory, and §Neuropathology Laboratory, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114; *Department of Neurosurgery, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115; and lHoward Hughes Medical Institute, and University of Utah, Salt Lake City, UT 84132 Communicated by Richard L. Sidman, June 28, 1989 (received for review February 2, 1989) ABSTRACT Astrocytomas, including glioblastoma multi- differentiated astrocytomas and the glioblastoma multiforme. forme, represent the most frequent and deadly primary neo- Although some patients with anaplastic astrocytoma respond plasms of the human nervous system. Despite a number of well to chemotherapy and/or radiotherapy, other patients do previous cytogenetic and oncogene studies primarily focusing not (2). Anaplastic astrocytomas, therefore, may be com- on malignant astrocytomas, the primary mechanism of tumor posed of several distinct biological subgroups, which cannot initiation has remained obscure. The loss or inactivation of be detected by standard histopathological techniques (6, 7). "tumor suppressor" genes are thought to play a fundamental Thus, alternative diagnostic tools, such as genetic markers, role in the development ofmany human cancers.
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD

    Supplementary Table S4. FGA Co-Expressed Gene List in LUAD

    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
  • Supplementary Material

    Supplementary Material

    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Neurol Neurosurg Psychiatry Page 1 / 45 SUPPLEMENTARY MATERIAL Appendix A1: Neuropsychological protocol. Appendix A2: Description of the four cases at the transitional stage. Table A1: Clinical status and center proportion in each batch. Table A2: Complete output from EdgeR. Table A3: List of the putative target genes. Table A4: Complete output from DIANA-miRPath v.3. Table A5: Comparison of studies investigating miRNAs from brain samples. Figure A1: Stratified nested cross-validation. Figure A2: Expression heatmap of miRNA signature. Figure A3: Bootstrapped ROC AUC scores. Figure A4: ROC AUC scores with 100 different fold splits. Figure A5: Presymptomatic subjects probability scores. Figure A6: Heatmap of the level of enrichment in KEGG pathways. Kmetzsch V, et al. J Neurol Neurosurg Psychiatry 2021; 92:485–493. doi: 10.1136/jnnp-2020-324647 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Neurol Neurosurg Psychiatry Appendix A1. Neuropsychological protocol The PREV-DEMALS cognitive evaluation included standardized neuropsychological tests to investigate all cognitive domains, and in particular frontal lobe functions. The scores were provided previously (Bertrand et al., 2018). Briefly, global cognitive efficiency was evaluated by means of Mini-Mental State Examination (MMSE) and Mattis Dementia Rating Scale (MDRS). Frontal executive functions were assessed with Frontal Assessment Battery (FAB), forward and backward digit spans, Trail Making Test part A and B (TMT-A and TMT-B), Wisconsin Card Sorting Test (WCST), and Symbol-Digit Modalities test.
  • 1714 Gene Comprehensive Cancer Panel Enriched for Clinically Actionable Genes with Additional Biologically Relevant Genes 400-500X Average Coverage on Tumor

    1714 Gene Comprehensive Cancer Panel Enriched for Clinically Actionable Genes with Additional Biologically Relevant Genes 400-500X Average Coverage on Tumor

    xO GENE PANEL 1714 gene comprehensive cancer panel enriched for clinically actionable genes with additional biologically relevant genes 400-500x average coverage on tumor Genes A-C Genes D-F Genes G-I Genes J-L AATK ATAD2B BTG1 CDH7 CREM DACH1 EPHA1 FES G6PC3 HGF IL18RAP JADE1 LMO1 ABCA1 ATF1 BTG2 CDK1 CRHR1 DACH2 EPHA2 FEV G6PD HIF1A IL1R1 JAK1 LMO2 ABCB1 ATM BTG3 CDK10 CRK DAXX EPHA3 FGF1 GAB1 HIF1AN IL1R2 JAK2 LMO7 ABCB11 ATR BTK CDK11A CRKL DBH EPHA4 FGF10 GAB2 HIST1H1E IL1RAP JAK3 LMTK2 ABCB4 ATRX BTRC CDK11B CRLF2 DCC EPHA5 FGF11 GABPA HIST1H3B IL20RA JARID2 LMTK3 ABCC1 AURKA BUB1 CDK12 CRTC1 DCUN1D1 EPHA6 FGF12 GALNT12 HIST1H4E IL20RB JAZF1 LPHN2 ABCC2 AURKB BUB1B CDK13 CRTC2 DCUN1D2 EPHA7 FGF13 GATA1 HLA-A IL21R JMJD1C LPHN3 ABCG1 AURKC BUB3 CDK14 CRTC3 DDB2 EPHA8 FGF14 GATA2 HLA-B IL22RA1 JMJD4 LPP ABCG2 AXIN1 C11orf30 CDK15 CSF1 DDIT3 EPHB1 FGF16 GATA3 HLF IL22RA2 JMJD6 LRP1B ABI1 AXIN2 CACNA1C CDK16 CSF1R DDR1 EPHB2 FGF17 GATA5 HLTF IL23R JMJD7 LRP5 ABL1 AXL CACNA1S CDK17 CSF2RA DDR2 EPHB3 FGF18 GATA6 HMGA1 IL2RA JMJD8 LRP6 ABL2 B2M CACNB2 CDK18 CSF2RB DDX3X EPHB4 FGF19 GDNF HMGA2 IL2RB JUN LRRK2 ACE BABAM1 CADM2 CDK19 CSF3R DDX5 EPHB6 FGF2 GFI1 HMGCR IL2RG JUNB LSM1 ACSL6 BACH1 CALR CDK2 CSK DDX6 EPOR FGF20 GFI1B HNF1A IL3 JUND LTK ACTA2 BACH2 CAMTA1 CDK20 CSNK1D DEK ERBB2 FGF21 GFRA4 HNF1B IL3RA JUP LYL1 ACTC1 BAG4 CAPRIN2 CDK3 CSNK1E DHFR ERBB3 FGF22 GGCX HNRNPA3 IL4R KAT2A LYN ACVR1 BAI3 CARD10 CDK4 CTCF DHH ERBB4 FGF23 GHR HOXA10 IL5RA KAT2B LZTR1 ACVR1B BAP1 CARD11 CDK5 CTCFL DIAPH1 ERCC1 FGF3 GID4 HOXA11 IL6R KAT5 ACVR2A
  • UC Riverside UCR Honors Capstones 2020-2021

    UC Riverside UCR Honors Capstones 2020-2021

    UC Riverside UCR Honors Capstones 2020-2021 Title Transcriptomic Analysis of Molecular Mechanisms of Neuroprotection by Neuregulin-1 Following Ischemic Stroke Permalink https://escholarship.org/uc/item/1c89b11s Author Bennett, Kimberly R. Publication Date 2021-08-13 Data Availability The data associated with this publication are within the manuscript. eScholarship.org Powered by the California Digital Library University of California TRANSCRIPTOMIC ANALYSIS OF MOLECULAR MECHANISMS OF NEUROPROTECTION BY NERUEGULIN-1 FOLLOWING ISCHEMIC STROKE By Kimberly R. Bennett A capstone project submitted for graduation with University Honors May 06, 2021 University Honors University of California, Riverside APPROVED Dr. Victor G. J. Rodgers Department of Bioengineering Dr. Byron D. Ford Department of Biomedical Sciences Dr. Richard Cardullo, Howard H Hays Jr. Chair University Honors ABSTRACT Ischemic stroke is a global health problem that is characterized by early neuronal death, apoptosis, inflammation, and oxidative stress following an obstruction of the blood supply to the brain. Previous studies have shown that ischemic stroke causes a release of pro-inflammatory cytokines that produce changes in gene expression, primarily in inflammation and cell death. Neuregulin-1 (NRG-1) is growth factor that has been investigated for its neuroprotective properties and ability to delay neuronal death following ischemic stroke. While NRG-1 has shown significant promise in preventing brain damage and stimulating post-injury repair following stroke, the mechanisms behind its neuroprotective effects are unclear. The goal of this research was to investigate the effects of NRG-1 treatment on ischemia-induced gene expression profiles following a permanent middle cerebral artery occlusion (pMCAO) in rat models. Rats were sacrificed twelve hours following vehicle or NRG-1 treatment.